{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:56:04Z","timestamp":1792598164247,"version":"4.5.0"},"reference-count":25,"publisher":"MyJove Corporation","issue":"218","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/67602","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T19:00:50Z","timestamp":1745607650000},"source":"Crossref","is-referenced-by-count":3,"title":["Preparation of Agar Bead Embedded <em>Mycobacterium abscessus<\/em> to Inoculate Immunocompetent Mice Intratracheally"],"prefix":"10.3791","author":[{"given":"Julianna","family":"Proietto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betelhem","family":"Tatek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Folvar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana C.","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilham M.","family":"Alshiraihi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Gonzalez-Juarrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Saliu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Vacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela Maria","family":"Cirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00e0","family":"Lore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Dick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Dartois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wassihun Wedajo","family":"Aragaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"issue":"6","key":"ref1","doi-asserted-by":"crossref","first-page":"e20220445","DOI":"10.1084\/jem.20220445","type":"journal-article","article-title":"Drug development challenges in nontuberculous mycobacterial lung disease: Tb to the rescue","volume":"219","author":"Dartois","year":"2022","unstructured":"Dartois, V. Dick, T. Drug development challenges in nontuberculous mycobacterial lung disease: Tb to the rescue. J Exp Med. 219 (6), e20220445 (2022).","journal-title":"J Exp Med"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ccm.2022.06.010","type":"journal-article","article-title":"Nontuberculous mycobacterial infections in cystic fibrosis","volume":"43","author":"Martiniano","year":"2022","unstructured":"Martiniano, S. L., Nick, J. A., Daley, C. L. Nontuberculous mycobacterial infections in cystic fibrosis. Clin Chest Med. 43 (4), 697-716 (2022).","journal-title":"Clin Chest Med"},{"issue":"7","key":"ref3","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1128\/AAC.02448-14","type":"journal-article","article-title":"Lack of antimicrobial bactericidal activity in mycobacterium abscessus","volume":"58","author":"Maurer","year":"2014","unstructured":"Maurer, F. P. et al. Lack of antimicrobial bactericidal activity in mycobacterium abscessus. Antimicrob Agents Chemother. 58 (7), 3828-3836 (2014).","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"ref4","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.drudis.2018.04.001","type":"journal-article","article-title":"Ntm drug discovery: Status, gaps and the way forward","volume":"23","author":"Wu","year":"2018","unstructured":"Wu, M. L., Aziz, D. B., Dartois, V., Dick, T. Ntm drug discovery: Status, gaps and the way forward. Drug Discov Today. 23 (8), 1502-1519 (2018).","journal-title":"Drug Discov Today"},{"issue":"4","key":"ref5","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1002\/med.21798","type":"journal-article","article-title":"Pipeline of anti-mycobacterium abscessus small molecules: Repurposable drugs and promising novel chemical entities","volume":"41","author":"Egorova","year":"2021","unstructured":"Egorova, A., Jackson, M., Gavrilyuk, V., Makarov, V. Pipeline of anti-mycobacterium abscessus small molecules: Repurposable drugs and promising novel chemical entities. Med Res Rev. 41 (4), 2350-2387 (2021).","journal-title":"Med Res Rev"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1055\/s-0028-1085705","type":"journal-article","article-title":"Using animal models to develop new treatments for tuberculosis","volume":"29","author":"Nuermberger","year":"2008","unstructured":"Nuermberger, E. Using animal models to develop new treatments for tuberculosis. Semin Respir Crit Care Med. 29 (5), 542-551 (2008).","journal-title":"Semin Respir Crit Care Med"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.TBTB2-0034-2017","type":"journal-article","article-title":"Preclinical efficacy testing of new drug candidates","volume":"5","author":"Nuermberger","year":"2017","unstructured":"Nuermberger, E. L. Preclinical efficacy testing of new drug candidates. Microbiol Spectr. 5 (3), 10.1128\/microbiolspec.tbtb2-0034-2017 (2017).","journal-title":"Microbiol Spectr"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"102301","DOI":"10.1016\/j.tube.2022.102301","type":"journal-article","article-title":"Preclinical murine models to study lung infection with mycobacterium abscessus complex","volume":"138","author":"Nicola","year":"2023","unstructured":"Nicola, F., Cirillo, D. M., Lore, N. I. Preclinical murine models to study lung infection with mycobacterium abscessus complex. Tuberculosis (Edinb). 138, 102301 (2023).","journal-title":"Tuberculosis (Edinb)"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"102503","DOI":"10.1016\/j.tube.2024.102503","type":"journal-article","article-title":"Preclinical murine models for the testing of antimicrobials against mycobacterium abscessus pulmonary infections: Current practices and recommendations","volume":"147","author":"Dartois","year":"2024","unstructured":"Dartois, V. et al. Preclinical murine models for the testing of antimicrobials against mycobacterium abscessus pulmonary infections: Current practices and recommendations. Tuberculosis (Edinb). 147, 102503 (2024).","journal-title":"Tuberculosis (Edinb)"},{"issue":"11","key":"ref10","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.1128\/AAC.00459-15","type":"journal-article","article-title":"Susceptibility of mycobacterium abscessus to antimycobacterial drugs in preclinical models","volume":"59","author":"Obregon-Henao","year":"2015","unstructured":"Obregon-Henao, A. et al. Susceptibility of mycobacterium abscessus to antimycobacterial drugs in preclinical models. Antimicrob Agents Chemother. 59 (11), 6904-6912 (2015).","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/infdis\/jit614","type":"journal-article","article-title":"In vivo evaluation of antibiotic activity against mycobacterium abscessus","volume":"209","author":"Lerat","year":"2014","unstructured":"Lerat, I. et al. In vivo evaluation of antibiotic activity against mycobacterium abscessus. J Infect Dis. 209 (6), 905-912 (2014).","journal-title":"J Infect Dis"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00614-2020","type":"journal-article","article-title":"Chronic infection by nontypeable haemophilus influenzae fuels airway inflammation","volume":"7","author":"Saliu","year":"2021","unstructured":"Saliu, F. et al. Chronic infection by nontypeable haemophilus influenzae fuels airway inflammation. ERJ Open Res. 7 (1), 00614-2020 (2021).","journal-title":"ERJ Open Res"},{"issue":"8","key":"ref13","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.3390\/pathogens12081053","type":"journal-article","article-title":"Biologically relevant murine models of chronic pseudomonas aeruginosa respiratory infection","volume":"12","author":"Rodgers","year":"2023","unstructured":"Rodgers, A. M. et al. Biologically relevant murine models of chronic pseudomonas aeruginosa respiratory infection. Pathogens. 12 (8), 1053 (2023).","journal-title":"Pathogens"},{"issue":"119","key":"ref14","first-page":"e55068","type":"journal-article","article-title":"A robust pneumonia model in immunocompetent rodents to evaluate antibacterial efficacy against s. Pneumoniae, h. Influenzae, k. Pneumoniae, p. Aeruginosa or a. Baumannii","author":"Hoover","year":"2017","unstructured":"Hoover, J. L. et al. A robust pneumonia model in immunocompetent rodents to evaluate antibacterial efficacy against s. Pneumoniae, h. Influenzae, k. Pneumoniae, p. Aeruginosa or a. Baumannii. J Vis Exp. 119, e55068 (2017).","journal-title":"J Vis Exp"},{"issue":"6","key":"ref15","doi-asserted-by":"crossref","first-page":"2201541","DOI":"10.1183\/13993003.01541-2022","type":"journal-article","article-title":"The aminoglycoside-modifying enzyme eis2 represents a new potential in vivo target for reducing antimicrobial drug resistance in mycobacterium abscessus complex","volume":"60","author":"Lore","year":"2022","unstructured":"Lore, N. I. et al. The aminoglycoside-modifying enzyme eis2 represents a new potential in vivo target for reducing antimicrobial drug resistance in mycobacterium abscessus complex. Eur Respir J. 60 (6), 2201541 (2022).","journal-title":"Eur Respir J"},{"issue":"18","key":"ref16","doi-asserted-by":"crossref","first-page":"6590","DOI":"10.3390\/ijms21186590","type":"journal-article","article-title":"A new model of chronic mycobacterium abscessus lung infection in immunocompetent mice","volume":"21","author":"Riva","year":"2020","unstructured":"Riva, C. et al. A new model of chronic mycobacterium abscessus lung infection in immunocompetent mice. Int J Mol Sci. 21 (18), 6590 (2020).","journal-title":"Int J Mol Sci"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1186\/s12879-022-07846-w","type":"journal-article","article-title":"A comparison of clinical development pathways to advance tuberculosis regimen development","volume":"22","author":"Chang","year":"2022","unstructured":"Chang, V., Phillips, P. P. J., Imperial, M. Z., Nahid, P., Savic, R. M. A comparison of clinical development pathways to advance tuberculosis regimen development. BMC Infect Dis. 22 (1), 920 (2022).","journal-title":"BMC Infect Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1277745","DOI":"10.3389\/fimmu.2023.1277745","type":"journal-article","article-title":"Pathological granuloma fibrosis induced by agar-embedded mycobacterium abscessus in c57bl\/6jnarl mice","volume":"14","author":"Yang","year":"2023","unstructured":"Yang, S. J. et al. Pathological granuloma fibrosis induced by agar-embedded mycobacterium abscessus in c57bl\/6jnarl mice. Front Immunol. 14, 1277745 (2023).","journal-title":"Front Immunol"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"e0254621","DOI":"10.1128\/spectrum.02546-21","type":"journal-article","article-title":"Combined host- and pathogen-directed therapy for the control of mycobacterium abscessus infection","volume":"10","author":"Poerio","year":"2022","unstructured":"Poerio, N. et al. Combined host- and pathogen-directed therapy for the control of mycobacterium abscessus infection. Microbiol Spectr. 10 (1), e0254621 (2022).","journal-title":"Microbiol Spectr"},{"issue":"7","key":"ref20","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1093\/jac\/dkaa110","type":"journal-article","article-title":"Inhaled tigecycline is effective against mycobacterium abscessus in vitro and in vivo","volume":"75","author":"Pearce","year":"2020","unstructured":"Pearce, C. et al. Inhaled tigecycline is effective against mycobacterium abscessus in vitro and in vivo. J Antimicrob Chemother. 75 (7), 1889-1894 (2020).","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/jac\/dkt451","type":"journal-article","article-title":"Gm-csf knockout mice for preclinical testing of agents with antimicrobial activity against mycobacterium abscessus","volume":"69","author":"De Groote","year":"2014","unstructured":"De Groote, M. A. et al. Gm-csf knockout mice for preclinical testing of agents with antimicrobial activity against mycobacterium abscessus. J Antimicrob Chemother. 69 (4), 1057-1064 (2014).","journal-title":"J Antimicrob Chemother"},{"issue":"85","key":"ref22","first-page":"e51019","type":"journal-article","article-title":"Long term chronic pseudomonas aeruginosa airway infection in mice","author":"Facchini","year":"2014","unstructured":"Facchini, M., De Fino, I., Riva, C., Bragonzi, A. Long term chronic pseudomonas aeruginosa airway infection in mice. J Vis Exp. 85, e51019 (2014).","journal-title":"J Vis Exp"},{"issue":"4","key":"ref23","doi-asserted-by":"crossref","first-page":"107278","DOI":"10.1016\/j.ijantimicag.2024.107278","type":"journal-article","article-title":"The novel drug candidate vomg kills mycobacterium abscessus and other pathogens by inhibiting cell division","volume":"64","author":"Degiacomi","year":"2024","unstructured":"Degiacomi, G. et al. The novel drug candidate vomg kills mycobacterium abscessus and other pathogens by inhibiting cell division. Int J Antimicrob Agents. 64 (4), 107278 (2024).","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"ref24","doi-asserted-by":"crossref","first-page":"e0053622","DOI":"10.1128\/aac.00536-22","type":"journal-article","article-title":"T405, a new penem, exhibits in vivo efficacy against m. Abscessus and synergy with beta-lactams imipenem and cefditoren","volume":"66","author":"Rimal","year":"2022","unstructured":"Rimal, B. et al. T405, a new penem, exhibits in vivo efficacy against m. Abscessus and synergy with beta-lactams imipenem and cefditoren. Antimicrob Agents Chemother. 66 (6), e0053622 (2022).","journal-title":"Antimicrob Agents Chemother"},{"key":"ref25","type":"book","article-title":"Progressive mycobacterium abscessus lung infection in c3heb\/fej mice associated with corticosteroid administration","volume-title":"bioRxiv","author":"Maggioncalda","year":"2018","unstructured":"Maggioncalda, E. C., Story-Roller, E., Ammerman, N. C., Nuermberger, E. L., Lamichhane, G. Progressive mycobacterium abscessus lung infection in c3heb\/fej mice associated with corticosteroid administration. bioRxiv. 10.1101\/418491 418491 (2018)."}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jove.com\/t\/67602\/preparation-agar-bead-embedded-mycobacterium-abscessus-to-inoculate","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:28:16Z","timestamp":1792596496000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jove.com\/t\/67602\/preparation-agar-bead-embedded-mycobacterium-abscessus-to-inoculate"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":25,"journal-issue":{"issue":"218","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.3791\/67602","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]}}}